The suppression of SH3BGRL is important for v-Rel-mediated transformation

Oncogene

Volumn 25, Issue 5, 2006, Pages 756-768

  Majid, S M ^a   Liss, A S ^a   You, M ^b   Bose Jr , H R ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

NF B; SH3BGR; SH3BGRL; Transformation; v Rel

Indexed keywords

PROTEIN; PROTEIN SH3; PROTEIN SH3BGRL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE MUTATION; GENE REPRESSION; GENE TRANSFER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPHOCYTE; NONHUMAN; ONCOGENE; ONCOGENE V REL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; DNA, COMPLEMENTARY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEINS V-REL; PROMOTER REGIONS (GENETICS); PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SRC HOMOLOGY DOMAINS;

ANIMALIA; AVES; MAMMALIA;

EID: 32244438118     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209107     Document Type: Article

References (82)

1. Akiyama Y, Kato S. (1974). Biken J 17: 105-116.
2. Baba TW, Giroir BP, Humphries EH. (1985). Virology 144: 139-151.
3. Baldwin Jr AS. (1996). Annu Rev Immunol 14: 649-683.
4. Ball LJ, Jarchau T, Oschkinat H, Walter U. (2002). FEBS 513: 45-52.
5. Barth CF, Ewert DL, Olson WC, Humphries EH. (1990). J Virol 64: 6054-6062.
6. Barzik M, Carl UD, Schubert W-D, Frank R, Wehland J, Heinz DW. (2001). J Mol Biol 309: 155-169.
7. Berleth ES, Henn AD, Gurtoo HL, Wollman R, Alderfer JL, Mihich E et al. (2000). Int J Immunopharmacol 22: 1137-1142.
8. Berleth ES, Nadadur S, Henn AD, Eppolito C, Shiojiri S, Gurtoo HL et al. (1999). Cancer Res 59: 5497-5506.
9. Bonizzi G, Karin M. (2004). Trends Immunol 25: 280-288.
10. Bose Jr HR. (1992). Biochim Biophys Acta 1114: 1-17.
11. Bull P, Morley KL, Hoekstra MF, Hunter T, Verma IM. (1990). Mol Cell Biol 10: 5473-5485.
12. Cao Y, Karin M. (2003). J. Mammary Gland Biol Neoplasia 8: 215-223.
13. Carrasco D, Rizzo CA, Dorfman K, Bravo R. (1996). EMBO J 15: 3640-3650.
14. Cesareni G, Panni S, Nardelli G, Castagnoli L. (2002). FEBS 513: 38-44.
15. Chen C, Okayama H. (1987). Mol Cell Biol 7: 2745-2752.
16. Chen F, Castranova V, Shi X. (2001). Am J Pathol 159: 387-397.
17. Cheng Q, Cant CA, Moll T, Hofer-Warbinek R, Wagner E, Birnstiel ML et al. (1994). J Biol Chem 269: 13551-13557.
18. Chiao PJ, Miyamoto S, Verma IM. (1994). Proc Natl Acad Sci USA 91: 28-32.
19. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin ASJ. (2000). Oncogene 19: 1123-1131.
20. Deindl E. (2001). Biotechniques 31: 1250-1252.
21. Denk A, Wirth T, Baumann B. (2000). Cytokine Growth Factor Rev 11: 303-320.
22. Dougherty JP, Temin HM. (1986). Mol Cell Biol 6: 4387-4395.
23. Dyer RB, Herzog NK. (1995). Biotechniques 19: 192-195.
24. Egeo A, Mazzocco M, Arrigo P, Vidal-Taboada JM, Oliva R, Pirola B et al. (1998). Biochem Biophys Res Commun 247: 302-306.
25. Franklin RB, Kang C-Y, Wan KM-M, Bose Jr HR. (1977). Virology 83: 313-321.
26. Fujii M, Minamino T, Nomura M, Miyamoto KI, Tanaka J, Seiki M. (1996). Oncogene 12: 2193-2202.
27. Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ et al. (2002). J Cell Sci 115: 141-151.
28. Gilmore TD. (1995). Regulation of Rel transcription complexes. In: Goodbourn S (ed). Frontiers in Molecular Biology: Eukaryotic Transcription. Oxford, England: Oxford University Press, pp 104-133.
29. Gilmore TD. (1999). Oncogene 18: 6925-6937.
30. Grabs D, Slepnev VI, Songyang Z, David C, Lynch M, Cantley LC et al. (1997). J Biol Chem 272: 13419-13425.
31. Hayden MS, Ghosh S. (2004). Genes Dev 18: 2195-2224.
32. Henn AD, Berleth ES, Mihich E, Ehrke MJ. (2001). FASEB 15: 1315-1317.
33. Hrdlicková R, Nehyba J, Bose Jr HR. (1995a). J Virol 69: 3369-3380.
34. Hrdlicková R, Nehyba J, Bose Jr HR. (2001). Mol Cell Biol 21: 6369-6386.
35. Hrdlicková R, Nehyba J, Humphries EH. (1994). J Virol 68: 308-319.
36. Hrdlicková R, Nehyba J, Roy A, Humphries EH, Bose Jr HR. (1995b). J Virol 69: 403-413.
37. Kabrun N, Hodgson JW, Doemer M, Mak G, Franza Jr BR, Enrietto PJ. (1991). Proc Natl Acad Sci USA 88: 1783-1787.
38. Karin M, Cao Y, Greten FR, Li ZW. (2002). Nat Rev Cancer 2: 301-310.
39. Kerr LD, Inoue JI, Davis N, Link E, Baeuerle PA, Bose Jr HR et al. (1991). Genes Dev 5: 1464-1476.
40. Kralova J, Liss AS, Bargmann W, Bose Jr HR. (1998). Mol Cell Biol 18: 2997-3009.
41. Kralova J, Liss AS, Bargmann W, Pendleton C, Varadarajan J, Ulug E et al. (2002). J Virol 76: 11960-11970.
42. Kralova J, Schatzle JD, Liss AS, Bargman W, Bose Jr HR. (1996). Oncogene 12: 2595-2604.
43. Lee RM, Gillet G, Burnside J, Thomas SJ, Neiman P. (1999). Genes Dev 13: 718-728.
44. Li Q, Verma IM. (2002). Nat Rev Immunol 2: 725-734.
45. Liss AS, Bose Jr HR. (2002). J Virol 76: 4928-4939.
46. Madrid LV, Baldwin Jr AS. (2003). Methods Mol Biol 223: 523-532.
47. Mayer BJ. (2001). J Cell Sci 114: 1253-1263.
48. Mazzocco M, Arrigo P, Egeo A, Maffei M, Vergano A, Di Lisi R et al. (2001). Biochem Biophys Res Commun 285: 540-545.
49. Mazzocco M, Maffei M, Egeo A, Vergano A, Arrigo P, Di Lisi R et al. (2002). Gene 291: 233-239.
50. Mecham BH, Klus GT, Strovel J, Augustus M, Byrne D, Bozso P et al. (2004). Nucleic Acids Res 32: e74.
51. Moore BE, Bose Jr HR. (1988). Virology 162: 377-387.
52. Moore PA, Ruben SM, Rosen CA. (1993). Mol Cell Biol 13: 1666-1674.
53. Moscovici C, Zeller N, Moscovici MG. (1982). Continuous lines of AMV-transformed non-producer cells: growth and oncogenic potential in the chick embryo. In: Revoltella RF, Pontieri GM, Basiliico C, Rovera G, Gallo RC, Subak-Sharpe JH (eds). Expression of Differentiated Functions in Cancer Cells. Raven Press: New York, pp. 435-449.
54. Nehyba J, Hrdličková R, Burnside J, Bose Jr HR. (2002). Mol Cell Biol 22: 3942-3957.
55. Nelson DM, Wahlfors JJ, Chen L, Onodera M, Morgan RA. (1998). Hum Gene Ther 9: 2401-2405.
56. Pahl HL. (1999). Oncogene 18: 6853-6866.
57. Petrenko O, Ischenko I, Enrietto PJ. (1997). Oncogene 15: 1671-1680.
58. Petsko G. (2002). Current Protocols in Bioinformatics. Hoboken: John Wiley & Sons, Inc.
59. Rao A, Kline K, Sanders BG. (1990). Cancer Res 50: 4764-4770.
60. Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC et al. (2003). Mol Cell Biol 23: 5738-5754.
61. Sachdev S, Hannink M. (1998). Mol Cell Biol 18: 5445-5456.
62. Sambrook J, Fritsch EF, Maniatis T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
63. Sarkar S, Gilmore TD. (1993). Oncogene 8: 2245-2252.
64. Scartenzzini P, Egeo A, Colella S, Fumagalli P, Arrigo P, Nizetic D et al. (1997). Hum Genet 99: 387-392.
65. Schagger H, Jagow GV. (1987). Anal Biochem 166: 368-379.
66. Schatzle JD, Kralova J, Bose Jr HR. (1995). J Virol 69: 5383-5390.
67. Schwartz RC, Witte ON. (1988). Virology 165: 182-190.
68. Shi X-B, Ma A-H, Tepper CG, Xia L, Gregg JP, Gandour-Edwards R et al. (2004). Prostate 60: 257-271.
69. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM et al. (1997). J Clin Invest 100: 2952-2960.
70. Stephens RM, Rice NR, Hiebsch RR, Bose Jr HR, Gilden RV. (1983). Proc Natl Acad Sci USA 80: 6229-6233.
71. Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gelinas C et al. (2002). Prostate 52: 183-200.
72. Suh J, Rabson AB. (2004). J Cell Biochem 91: 100-117.
73. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M et al. (2000). Prostate 44: 91-103.
74. Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Page N et al (2001). Science 294: 2364-2368.
75. Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M et al. (1998). Neuron 4: 717-726.
76. White DW, Roy A, Gilmore TD. (1995). Oncogene 10: 857-868.
77. Wilhelmsen KC, Eggleton K, Temin HM. (1984). J Virol 52: 172-182.
78. You M, Bose Jr HR. (1998). Methods Enzymol 16: 373-385.
79. Zhang G, Slaughter C, Humphries EH. (1995). Mol Cell Biol 15: 1806-1816.
80. Zhang GQ, Humphries EH. (1996). Oncogene 12: 1153-1157.
81. Zhou JR, Yu L, Zerbini LF, Libermann TA, Blackburn GL. (2004). Int J Cancer 110: 800-806.
82. Zone W-X, Farrell M, Bash J, Gélinas C. (1997). Oncogene 15: 971-980.